These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 2043287)

  • 1. Side effects of ranitidine.
    Vial T; Goubier C; Bergeret A; Cabrera F; Evreux JC; Descotes J
    Drug Saf; 1991; 6(2):94-117. PubMed ID: 2043287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine.
    Richards DA
    J Clin Gastroenterol; 1983; 5 Suppl 1():81-90. PubMed ID: 6317740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.
    Powell JR; Donn KH
    J Clin Gastroenterol; 1983; 5 Suppl 1():95-113. PubMed ID: 6140286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of cimetidine and ranitidine at some cholinergic sites: implications in toxicology and anesthesia.
    Gwee MC; Cheah LS
    Life Sci; 1986 Aug; 39(5):383-8. PubMed ID: 2874464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible cholestatic injury from ranitidine with a review of the literature.
    Ramrakhiani S; Brunt EM; Bacon BR
    Am J Gastroenterol; 1998 May; 93(5):822-6. PubMed ID: 9625136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cimetidine and ranitidine on cardiovascular drugs.
    Baciewicz AM; Baciewicz FA
    Am Heart J; 1989 Jul; 118(1):144-54. PubMed ID: 2662728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic effects of drugs used in the treatment of peptic ulcer disease.
    Lewis JH
    Am J Gastroenterol; 1987 Oct; 82(10):987-1003. PubMed ID: 2889354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H2 antagonists and the nervous system.
    Epstein CM
    Am Fam Physician; 1985 Dec; 32(6):109-12. PubMed ID: 4072863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions and interactions with H2-receptor antagonists.
    Penston J; Wormsley KG
    Med Toxicol; 1986; 1(3):192-216. PubMed ID: 2878343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.
    Andersen M; Schou JS
    Pharmacol Toxicol; 1991 Oct; 69(4):253-8. PubMed ID: 1683484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of infectious complications associated with the use of histamine2-receptor antagonists in critically ill trauma patients.
    O'Keefe GE; Gentilello LM; Maier RV
    Ann Surg; 1998 Jan; 227(1):120-5. PubMed ID: 9445119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematological adverse effects of histamine H2-receptor antagonists.
    Aymard JP; Aymard B; Netter P; Bannwarth B; Trechot P; Streiff F
    Med Toxicol Adverse Drug Exp; 1988; 3(6):430-48. PubMed ID: 2905759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the differences between the H2-receptor antagonists?
    Schunack W
    Aliment Pharmacol Ther; 1987; 1 Suppl 1():493S-503S. PubMed ID: 2908767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro.
    Banning MM; Curtis MJ
    Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mania associated with ranitidine: a case report and review of literature.
    Mauran A; Goze T; Abadie D; Bondon-Guitton E; Chevrel P; Schmitt L; Montastruc JL; Montastruc F
    Fundam Clin Pharmacol; 2016 Aug; 30(4):294-6. PubMed ID: 27083385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems associated with medical treatment of peptic ulcer disease.
    Zimmerman TW
    Am J Med; 1984 Nov; 77(5B):51-6. PubMed ID: 6095662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Side effects and safety of the new histamine H2 receptor antagonist ranitidine in the long-term treatment of patients with stomach and duodenal ulcers].
    Meryn S; Pötzi R; Brunner H; Pesendorfer FX; Pamperl H
    Wien Klin Wochenschr; 1983 Apr; 95(9):310-2. PubMed ID: 6137111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine-induced anaphylaxis: clinical features, cross-reactivity, and skin testing.
    Park KH; Pai J; Song DG; Sim DW; Park HJ; Lee JH; Jeong KY; Pan CH; Shin I; Park JW
    Clin Exp Allergy; 2016 Apr; 46(4):631-9. PubMed ID: 26764898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine: a new H2-receptor antagonist.
    Berner BD; Conner CS; Sawyer DR; Siepler JK
    Clin Pharm; 1982; 1(6):499-509. PubMed ID: 6309467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.
    Hahm KB; Kim WH; Lee SI; Kang JK; Park IS
    Scand J Gastroenterol; 1995 Mar; 30(3):265-71. PubMed ID: 7770717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.